Active Pharmaceutical Ingredient Market
                     Active Pharmaceutical 
Ingredient Market
Set to Exceed USD 306.1 Billion By 2027 | CAGR: 7.1% 
“Active Pharmaceutical Ingredient (API) Market Share, Size, 
Trends, Industry Analysis Report, By Product Type (mAb, 
Immunoglobulin, Cytokines, Insulin, Peptide Hormones, 
Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule 
Antibiotics, Highly Potent Active Pharmaceutical Ingredient 
(HPAPI), and Others); By Form (Aqueous, Non-Aqueous 
Liquid, and Dry Powder); By Manufacturer Type (Captive, 
and Merchant); By Application; By Regions; Segment 
Forecast, 2020 - 2027”
 Active Pharmaceutical Ingredient Market Estimate & Forecast to 2027
The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 
2027 according to a new study by Polaris Market Research. The report gives a detailed insight into 
current market dynamics and provides analysis on future market growth.
 
Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product 
(FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, 
diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the 
human body. Drug products are composed of various components, API is the primary ingredient of a drug 
product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline 
form, thermo-dynamically. 
 
The prominent factors favoring the global market include the sudden outbreak of novel corona virus, 
which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth. 
Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other 
infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For 
instance, according to a report published in March 2020, by World Health Organization (WHO), the 
number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number 
would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle 
diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global 
market.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 2
Active Pharmaceutical Ingredient Market Scope
By Product Type By Form By By Application  By Region
Manufactur
er Type
• Monoclonal • Aqueou • Captive • Cardiology • North America 
Antibodies s • Merchant • Oncology (U.S., Canada)
• Immunoglobulin • Non- • CNS & Neurology • Europe (France, 
• Cytokines Aqueou • Orthopedic Germany, UK, 
• Insulin s • Endocrinology Italy, Spain, 
• Peptide • Dry • Pulmonology Netherlands, 
Hormones Powder • Gastroenterology Austria)
• Blood Factors • Nephrology • Asia Pacific 
• Peptide • Ophthalmology (Japan, China, 
Antibiotics • Others India, Malaysia, 
• Vaccines Indonesia. South 
• Small Molecule Korea)
Antibiotics • Latin America 
• Highly Potent (Brazil, Mexico, 
Active Argentina)
Pharmaceutical • MEA (Saudi 
Ingredient Arabia, UAE, 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
(HPAPI)                    Request for sample Israel, South 
• Others Africa)
Active Pharmaceutical Ingredient Market Estimate & Forecast to 2027
Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, 
Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and 
Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., 
Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries 
Ltd. are some of the key players operating in the global market.
Access Research Report On Active Pharmaceutical Ingredient Market
 
Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising 
demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases 
such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, 
which are responsible for the majority of deaths across the globe, the innovation and demand for 
pharmaceuticals has witnessed elevated graph over the few decades.
 
Major players in the market are strengthening their capabilities to enhance their product portfolio and 
further establish their market place. For instance, on July, 2020, Advert International signed an 
agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro 
Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is 
expected to leverage their operational and financial resources across the globe to scale RA Chem 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
Pharma.
Active Pharmaceutical Ingredient Market Size
Request for Sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Active Pharmaceutical Ingredient Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980